Tue, Jan 27, 2015, 5:14 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

NVIDIA Corporation Message Board

j7777kxx 5440 posts  |  Last Activity: 21 minutes ago Member since: Sep 27, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Have to put it back on my buy radar for later this week if it approaches 200 day moving average of $19.10. This stock is a trader's dream.

  • Of Course Not.....will they deliver someone else's cure for cancer to the tumor. A distinct possibility. Bind is using Chemistry to deliver cancer causing killing agents to the tumor, without the adverse affects to healthly cells.

    Think about it, There are millions of cancer killing chemicals....but alas they kill the healthy cells and the patient dies.But just what if the chemical is delivered to the cancer and by passes the healthy cells. That's what's Bind Therapeutics is all about.

    Big Pharma is kicking the tires.....will see as it goes.

    Sentiment: Strong Buy

  • Reply to

    The Lights Are Going Out In Houston

    by j7777kxx Nov 30, 2014 6:27 PM
    j7777kxx j7777kxx Dec 1, 2014 12:19 PM Flag

    Wellhead Oil Prices from RMOJ.

    Gas & Crude Oil Prices11/28
    Area Price/bbl,
    West Texas Intermediate 62.77
    Central Montana 52.57
    Northwest Montana Sour 52.25
    Williston Basin Sweet 49.69
    Williston Basin Sour 40.58
    Wyoming General Sour 44.75
    Wyoming Sweet (Powder Rv Bsn) 54.40
    Colorado D-J Basin 53.80
    Four Corners 61.77
    Nebraska 53.90
    Southeastern Colorado 53.00
    Western Colorado 49.88
    Kansas Sweet NW 54.25
    Kansas Sweet SW 54.50

  • Reminds me of Dec 1985

  • Reply to

    New BIND Linkedin Job Postings

    by j7777kxx Nov 24, 2014 4:09 PM
    j7777kxx j7777kxx Nov 25, 2014 6:45 PM Flag

    I new job posting 3 hrs. ago for Bind:

    Scientist, Polymer Chemistry:

    •Ph.D. in Chemistry, Chemical Engineering or Material Science with relevant doctoral/post-doctoral research experience or Master's Degree and 6+ years of relevant industrial experience.
    •Training and research experience in the field of polymer science or polymer chemistry is required, including hands-on experience in the areas of polymer synthesis using one or more polymerization processes (ring opening, free radical, ionic, condensation polymerization under solution, emulsion, suspension or melt conditions). Knowledge and understanding of end functional polymers and block copolymers comprised of biodegradable and biocompatible components and their application for development of biomaterials and drug delivery devices is a plus.
    •In-depth understanding and experience with polymer characterization techniques (NMR spectroscopy, Size Exclusion Chromatography, Light Scattering, DSC, dilute solution viscometry, GC, ICP-OES/MS and LC-MS) as applied to determination of polymer composition, end group structure, molar mass determination and purity is required.
    •Proven track record of scientific achievement in academic research or industrial R&D and ability to excel in a multi-disciplinary work environment is a plus. Experience working with hydrogels, polyelectrolytes, micro-, nano-particles, polymer thin-films or other self-assembled structures is valuable.

    Partner work, internal work, who knows?....but the company is Hiring!

    Sentiment: Strong Buy

  • Reply to

    A Layman's Take On Bind

    by j7777kxx Nov 22, 2014 7:19 PM
    j7777kxx j7777kxx Nov 24, 2014 5:20 PM Flag

    I have been reading the phase 2 and phase 3 clinical trial results of other cancer drugs approved by the FDA for a while now. As a whole they are not overwhelmingly positive to say the least and no better than Bind-014. It seems just about anything gets approved when relatively safe, some positive results, especially when the drug fights cancers where no other drugs are available. Hence Bind-014 for Non Small Cell Tumors with KRAS mutations is a very big deal

    One other very positive thing about BIND-014 is it is a special formulation of docetaxel which means BIND can apply under the 505b2 application process which is a much shorter and a much cheaper process for FDA approval, because they can use all published literature on docetaxel in their application.

    Sentiment: Strong Buy

  • Senior Scientist, Analytical Development
    Manager, New Product Development
    Associate Director/Director, Analytical Development
    Head of Investor and Public Relations

    Looks link Bind management is gearing up.........

    P.S. Not that many shares left for shorts to borrow.....so guess what?

    Sentiment: Strong Buy

  • I have followed Bind for over a year because I was intrigued with what they were doing. I just like the science of things....my Science degree is so old that in my time it was "Plastics", not nanotechnology, but who cares. Relatively early on I thought....this company is positioning itself to bought out by Big Pharma. As they moved forward with their Accurrin Docetaxel drug (Note: off patent), I thought well that's nice...patent a new drug Bind-014 which is the generic Docetaxel, but with a new delivery system. Then claim and aim to prove better results and less drug complications by your new delivery system. Sounded like the Holy Grail.....better results, less complications.

    Now how many Big Pharma companies have had blockbuster drugs come off patent. Quite a few. Some have come up with better drug delivery systems like Wellbutrin XL once a day dosing vs twice a day and had their patent renewed.

    I see Bind attempting to do the same thing. The partner colloborations with Pfizer, Roche, Astrozeneca, and Merck are simply the same thing. For a fee they are kicking the tires with new pre-clinical compounds that kill cancer or other diseases, but are too toxic. If these remotely work, it would not take a Genius to think intimes of what Blockbuster drugs are going off patent that can be reformulated using Bind's technology that would delivery significant less drug complications allowing the company to extend their patent protections for many more years.

    I bought Friday at the Close for the record.


    Sentiment: Strong Buy

  • Possibly a good sign.....hold your breath until Friday A/H if Nvidia Management plays true to form.

    PS - Nexus 9 is barely registering on Amazon. I am placing my hopes on Nvidia Shield....It's consistently registering around 50th to 70th best seller Tablet on Amazon.....Far and away selling better than Nexus 9. Take a look at Europe thru Amazon UK or Amazon Germany....neither are in the top 1000.

    Tegra is a dead horse boys....the company is off riding other much more lucrative things......Just need that Tegra division layoff to push it up to $22..


  • It's a complete lack of buyers. They read and comprehend the Option Sellers posts, but they say.....Nah, not at these levels. I blame Nvidia's Investor Relation and PR Department. The message presented is confused.

    Today was a great example. New Tesla Card announced, following major win in National Labs Supercomputers.

    Intel sketches a new Xeon PHI coprocessor on a napkin and their stock goes up. AMD announces nothing but PR buys the drinks on Bourbon street and their stock goes up. IBM goes up but alas Nvidia PPS goes down.

    What gives...........it must be the option sellers....everyone knows who you are are.

    I will leave you with this.....Nvidia Shield is outselling Nexus 9 on Amazon. Sounds good right....They are selling at maybe a rate of 10,000 a month.

    Time for a work force reduction in the Tegra division for sure. Yhen Nvdarocks you might wake up to a $30 price per share.

  • Obviously no real buyers at these levels.

  • Reply to

    Apple Insider too funny

    by nvdarocks Nov 15, 2014 6:46 AM
    j7777kxx j7777kxx Nov 16, 2014 9:01 PM Flag

    "While he claims he doesn't trade options, his most recent bullish arrival was followed way too closely by these negative, FUD-filled posts, and he's likely long puts, or simply didn't get what he wanted from his short-term call trade and wants to see the stock fall back so he can try again, or make money on the pullback. The "tell" was his post about the kind of car he was going to be able to buy if the stock got to 20.75 and the two higher prices he mentioned. It's just highly unlikely he would have taken a position of 10-20k (or even more) shares to try to make the money for said car.

    Changing one's opinion on a stock can happen at any time, that's for sure. But, he has a pattern of doing this over and over and while he may indeed have experience at TXN, I really don't think he sees that NVDA is a completely transformed company with a TAM that has grown to 5-10 times what it was and most of those revenue streams are in their infancy."

    Ah Kvimax1, you raised so many questions I don't know if if I can answer them all. First off I do not trade options except when I had I inside information 30 years ago...and just twice. It's a fools game as I am sure you would agree...unless you are writing those options......then as Ibexx use to say....it's money in the bank!

    Now is Nvidia is a completely transformed company as you say.........It's an open question TAM may be bigger, but the players are the same......watch the insider sells next week.

    Plus Samsung is going to the mat with their countersuit......doesn't mean that Nvidia might win a little or lot in 2016...but your near term options really suck......LOL

  • j7777kxx j7777kxx Nov 16, 2014 2:08 AM Flag

    He is gone. We have eir951, Krivmax, and Nvdarocks to take his place. LOL

  • j7777kxx j7777kxx Nov 15, 2014 9:04 PM Flag

    you will find out next week....LOL good luck with your options.

  • Reply to

    Apple Insider too funny

    by nvdarocks Nov 15, 2014 6:46 AM
    j7777kxx j7777kxx Nov 15, 2014 8:03 PM Flag

    eir951.....History repeats...need I say Motorola Zoom. Apparently there is nothing special with Nvidia mobile GPUs except the price as long as IMG Power VRG is out that and used by Apple. What validates the usefulness of K1 in a big way is the total lack of uptake by mfg. Perhaps K1 with Maxwell will turn the tide, but again history will probably repeat.

    Go to Amazon and check out the Nvidia Shield. It is selling more than the Nexus 9. Don't get too exited it probably selling 10,000 to 15 000 units a month.

    Just a corollary, you can look it up of course. Atmel cited in their 3Q conference call that q4 would be down. Blamed Nvidia for saying they had all they needed for Q4 builds.

    Time for a serious reduction in workforce in the Tegra unit in my opinion.

  • j7777kxx j7777kxx Nov 15, 2014 6:29 PM Flag

    "Intel is providing billions in concessions on socs. Hard to compete where the power savings from ARM is not needed."

    Agree.....but this is also billed as a gaming device and Intel chose to use Imagination Tech. PVG GPUs, when they could have used their own licensed Nvidia GPU tech. Why? probably because it's better and cheaper for them. This is concerning....Nvidia's only licensed GPU customer....and they decided to go with someone else that they have to pay extra for.....So come on Nvidia fanboys....tell me again why Apple who uses a IMG Tech GPU's will suddenly take a liscense from Nvidia.....Bottom line Nvidia's whole Tegra investment is riding on the outcome of their patent infringement lawsuits against Samsung and Qualcomm and Samsungs cross suit in Virginia. And honestly it is not a slam dunk by any means.

  • Technical specifications


    1.8GHz Quad Core, Intel® Atom™

    Imagination PowerVR Series 6 Graphics 2D/3D Engine


    1GB RAM

    8GB storage⁴


    18W DC power

    HDMI® out (1920 x 1080 @ 60Hz)

    Micro-USB 2.0


    802.11ac 2x2 (MIMO)

    Bluetooth 4.1

    At Google IO day I thought nvidia had a lock on this! Probable something to do with the price?

  • j7777kxx j7777kxx Nov 15, 2014 3:05 PM Flag

    Sep 22, 2014 SHOQUIST DEBORA
    2,021 Direct Option Exercise at $12.62 per share. 25,505
    Sep 22, 2014 SHOQUIST DEBORA
    2,021 Direct Automatic Sale at $18.96 per share. 38,318
    Sep 18, 2014 SHOQUIST DEBORA
    7,488 Direct Automatic Sale at $19.24 per share. 144,069
    Sep 18, 2014 SHOQUIST DEBORA
    7,488 Direct Option Exercise at $16 per share. 119,808
    Sep 17, 2014 BYRON MICHAEL
    2,303 Direct Disposition (Non Open Market) at $19.15 per share. 44,102
    Sep 17, 2014 KRESS COLETTE
    26,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
    Sep 17, 2014 KRESS COLETTE
    22,828 Direct Disposition (Non Open Market) at $19.15 per share. 437,156
    Sep 17, 2014 SHOQUIST DEBORA
    17,500 Direct Acquisition (Non Open Market) at $0 per share. N/A
    Sep 17, 2014 SHOQUIST DEBORA
    7,740 Direct Disposition (Non Open Market) at $19.15 per share. 148,221
    Sep 17, 2014 SHANNON DAVID M
    13,000 Direct Acquisition (Non Open Market) at $0 per share. N/A
    Sep 17, 2014 HUANG JEN HSUN
    12,686 Direct Disposition (Non Open Market) at $19.15 per share. 242,936
    Sep 17, 2014 BYRON MICHAEL
    5,950 Direct Acquisition (Non Open Market) at $0 per share. N/A
    Sep 17, 2014 SHANNON DAVID M
    8,757 Direct Disposition (Non Open Market) at $19.15 per share. 167,696
    Sep 17, 2014 PURI AJAY K
    9,482 Direct Disposition (Non Open Market) at $19.15 per share. 181,580
    Sep 17, 2014 PURI AJAY K
    17,500 Direct Acquisition (Non Open Market) at $0 per share. N/A
    Sep 8, 2014 SEAWELL A BROOKE
    48,000 Direct Option Exercise at $9.67 per share. 464,160
    Sep 8, 2014 SEAWELL A BROOKE
    48,000 Direct Sale at $19.95 per share. 957,600

  • j7777kxx j7777kxx Nov 14, 2014 8:07 PM Flag

    Two different suits....The Virginia suit is about Samsung patents that describe protocols on how to attach to memory and or cache. Samsung has been a memory supplier for 30 years and has multiple 10,000's patents centered around memory.....so yes I believe Nvidia will lose this court case.

    Nvidia's ITC case is about GPU patents and yes I believe Nvidia will win.

    The problem I see is it is simply a race to who gets judgement and an exclusion order first. All of Nvidia's products are affected and almost all of Samsung's products are affected. When the Shxx hits the fan, then a licensing agreement can be worked out.....in the meantime.......what that may entail and what the price of the stock will be at that point is anyone's question. I refer you to the Intel Nvidia squabble in 2010.

    Now there is one way to tell conclusively what Nvidia's Top management thinks....watch the insider stock sales...and don't pay any attention to that BS of automatic sales....they can be suspended by one little phone call.

    I will reference you to the Director that sold a large block on 9/4 the day the ITC lawsuit was filed and all top management selling blocks over the next two weeks.

    I would hope Nvidia's BOD bans all sales insider stock sales for the duration of these court proceedings!

    Let's see what they do?

  • Welcome to the Rocket Docket

    Just across the Potomac river, within eyesight of downtown Washington, D.C., sits historic Olde Town Alexandria, Virginia, home of quaint antique shops, cobble-stoned streets, untold George Washington Slept Here signs, and . . . the Rocket Docket. Though not one of the many tourist attractions gracing this old American city, the Rocket Docket should attract the attention of any multinational corporation. For the day just might come when International Widgets, a Luxembourg corporation doing business throughout the globe, finds itself bringing or defending a lawsuit in the United States District Court for the Eastern District of Virginia.

    This court is one of the 94 federal district courts in the United States, the courts responsible for hearing all patent infringement cases and a broad array of other cases. Because of this particular court's unique system of case management, it has earned the reputation as the fastest and most efficient federal court in the United States. Hence its nickname, the Rocket Docket. Civil cases filed there do not languish. Instead they often proceed with breakneck speed, challenging the wits and skill of even the most seasoned of trial lawyers.

    According to the philosophy of the Rocket Docket, the single greatest motivator for parties to settle their differences is the prospect of an early, fixed trial date. The court manages its criminal and civil dockets in such a way that criminal cases will not "bump" civil trial dates off the calendar. Thus, when a trial date is set, you can consider it etched in stone. On average, a case filed in the Rocket Docket reaches trial within six to seven months, regardless of its size and complexity (e.g., the number of patents asserted) or the number of parties involved.
    Just the tip of the iceberg I am afraid.

19.63-0.99(-4.78%)Jan 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.